Prevalence of Hyperuricemia and Gout in Mainland China from 2000 to 2014: A Systematic Review and Meta-Analysis.
Liu R, Han C, Wu D, Xia X, Gu J, Guan H, Shan Z, Teng W. · 2015
Read Prevalence of Hyperuricemia and Gout in Mainland China from 2000 to 2014: A Systematic Review and Meta-Analysis. by Liu R, Han C, Wu D, Xia X, Gu J, Guan H, Shan Z, Teng W. (2015) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4657091.txt.
Introduction
A team led by Ru Liu published a 2015 systematic review and meta-analysis of high uric acid and gout prevalence in mainland China. Raised uric acid, called hyperuricemia, feeds gout and tracks with diabetes, blood pressure, and kidney disease. The team searched five databases for studies from 2000 to 2014. The work appeared in BioMed Research International.
Thirty-six articles provided forty-four studies. Pooled prevalence came to 13.3 percent for hyperuricemia and 1.1 percent for gout. A statistical check for publication bias did not overturn the estimates. Region, city versus countryside, coastal versus inland setting, wealth level, and sex all related to prevalence. The authors offer the figures as a base for local public health planning in China.
Catalog record
| CREATOR | Liu R, Han C, Wu D, Xia X, Gu J, Guan H, Shan Z, Teng W. |
|---|---|
| YEAR | 2015 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 36 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Prevalence of Hyperuricemia and Gout in Mainland China from 2000 to 2014: A Systematic Review and Meta-Analysis By Rui Liu, Cheng Han, Di Wu, Xinghai Xia, Jianqiu Gu, Haixia Guan, Zhongyan Shan, Weiping Teng Published in: BioMed Research International DOI: 10.1155/2015/762820 ABSTRACT Abstract We systematically identified the prevalence of hyperuricemia and gout in mainland China and provided informative data that can be used to create appropriate local public health policies. Relevant articles from 2000 to 2014 were identified by searching 5 electronic databases: PubMed, Google Scholar, Chinese Wanfang, CNKI, and Chongqing VIP. All of the calculations were performed using the Stata 11.0 and SPSS 20.0 software. The eligible articles (n = 36; 3 in English and 33 in Chinese) included 44 studies (38 regarding hyperuricemia and 6 regarding gout). The pooled prevalence of hyperuricemia and gout was 13.3% (95% CI: 11.9%, 14.6%) and 1.1% (95% CI: 0.7%, 1.5%), respectively. Although publication bias was observed, the results did not change after a trim and fill test, indicating that that impact of this bias was likely insignificant. The prevalence of hyperuricemia and gout was high in mainland China. The subgroup analysis suggested that the geographical region, whether the residents dwell in urban or rural and coastal or inland areas, the economic level, and sex may be associated with prevalence. 1. INTRODUCTION Serum uric acid is the final enzymatic product of purine metabolism [1, 2]. Abnormalities in serum uric acid metabolism may cause hyperuricemia and gout. Hyperuricemia is the result of interactions among multiple factors, including sex, age, genetics, lifestyle, and environment [3]. Several studies have suggested that hyperuricemia is associated with many diseases, including diabetes mellitus [4], hypertension [5, 6], stroke [2, 7], dyslipidemia [8], chronic kidney disease [9], cardiovascular events, and heart failure [10–12]. Hyperuricemia is considered to be a precursor of gout as the deposition of urate crystals in the joints results in an acute inflammatory response. Deposition in the soft tissue can lead to tophi [13–15]. Gout is also a serious health issue and is an independent risk factor for heart failure and metabolic syndrome [16, 17]. In recent years, an increasing trend in the prevalence of hyperuricemia and gout has been observed in epidemiological studies [13, 18–21], and both diseases have become public health problems that need to be solved quickly. Due to rapid economic development, the lifestyle of the Chinese has changed greatly, a huge transition from a dietary pattern traditionally based on carbohydrates and vegetables to a pattern that relies on meat, dairy products, and other purine-rich foods that are closely related to hyperuricemia and gout [22, 23]. As a large developing country, China has marked regional differences and varied populations. To date, most investigations have been limited to certain areas or have focused on specific occupations. Therefore, a comprehensive study on the epidemiology of hyperuricemia and gout in the entire mainland China is needed. As most of the published data are in Chinese, we present our study in the widely read English medium. Obtaining an accurate prevalence of hyperuricemia and gout is important to help us formulate appropriate local public health policies. In addition, such a study will benefit the people through health education by increasing awareness of hyperuricemia and gout and also the importance of improving lifestyle and maintaining a healthy diet. Due to varied geographic locations that include diverse populations and different socioeconomic conditions, a unified epidemiological investigation about the prevalence of hyperuricemia and gout remains difficult. We conducted a meta-analysis regarding the prevalence of both diseases in mainland China between January 2000 and December 2014 to determine the epidemiology and to review the results from previous studies. 2. METHODS 2.1. Search Strategy We manually searched all of the literatures regarding population-based research on the prevalence of hyperuricemia and gout from 2000 to 2014 using the PubMed, Google Scholar, CNKI (Chinese National Knowledge Infrastructure), Chinese Wangfang, and Chongqing VIP electronic databases. The keywords for search were “uric acid,” “HUA,” “HU,” “hyperuricemia,” “gout,” “prevalence(s),” “incidence(s),” and “epidemiology.” To find additional studies, the reference lists of the identified studies were also examined. 2.2. Inclusion and Exclusion Criteria Papers were included if they met all of the following criteria: (1) all study participants living in mainland China; (2) study data being general population-based rather than hospital-based; (3) prevalence rate being also analyzed by according to sex; (4) accurate diagnostic criteria and clear study date; and (5) the most detailed study of duplicate studies on the same population. Studies were excluded if they (1) were not original research, such as a review or case report, (2) included participants with concomitant diseases or had medication history known to affect uric acid metabolism, or (3) focused on specific population groups, such as teenagers, elderly people, or single gender, or a certain occupation. 2.3. Definition of Hyperuricemia and Gout The diagnostic criteria for hyperuricemia varied among the studies; we have listed each criterion in Table 1. The diagnostic criteria for gout were listed in Table 2 [24, 25]. [Table: Characteristics of studies on the prevalence of hyperuricemia and gout.] [Table: Gout classification criteria.] 2.4. Data Extraction Two reviewers searched the literature independently. Any disagreement on data extraction between the two reviewers was mediated by discussion [26]. Figure 1 shows the literature-search process. We recorded the characteristics of all the included papers in Table 1, including the title, author's name, publication date, study year, study population, geographic area, rural/urban, inland/coastal, sample size, case, prevalence, and diagnostic criterion. [Figure: Flow diagram for the literature-search process.] 2.5. Statistical Analysis Pooled prevalence and 95% confidence intervals (CIs) were calculated to estimate the prevalence of hyperuricemia and gout in mainland China. We adopted the Chi-squared-based Q test and the I 2 test to evaluate the heterogeneity of the studies; 25%, 50%, and 75% were considered low, moderate, and high levels, respectively [27, 28]. If the level of heterogeneity was moderate or high, we used a random-effects meta-analysis model instead of a fixed-effects model. To perform a secondary analysis and to address heterogeneity, a subgroup analysis was required. Egger's test was used to estimate publication bias. A P value less than 0.05 was considered statistically significant. Meta-analysis was calculated using Stata Version 11.0 (Stata Corp LP, College Station, TX, USA). Significant differences in prevalence among the groups were examined through the Chi-square test using SPSS Version 20.0 (SPSS Software, Chicago, IL, USA). All figures were generated using Stata 11.0 (Stata Corp LP, College Station, TX, USA) or Microsoft PowerPoint (Microsoft, Redmond, USA). 3. RESULTS 3.1. Characteristics of Included Studies A total of 604 articles were identified (Figure 1). After screening for population base, study type, relevancy, and duplicates, 36 literary papers (3 in English and 33 in Chinese) containing 44 studies (38 regarding hyperuricemia and 6 regarding gout) met our inclusion criteria. A detailed description of these studies is provided in Table 1. 3.2. Pooled Prevalence of Hyperuricemia and Gout As shown in Figure 2, the pooled prevalence of hyperuricemia was 13.3% (95% CI: 11.9%, 14.6%), with the prevalence ranging from 5.5% to 23.6%. As shown in Figure 3, the pooled prevalence of gout was 1.1% (95% CI: 0.7%, 1.5%), with a range of 0.4–1.5%. [Figure: Forest plot of the pooled prevalence of hyperuricemia in mainland